Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea

BACKGROUND/AIMS: Chronic hepatitis C (CHC) is a major comorbidity in patients with hemophilia. However, there are no published data on the efficacy of antiviral therapy in Korea. We assessed the safety and efficacy of combination therapy with peginterferon α-2a plus ribavirin for CHC in hemophilia....

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Suh Yoon, Lee, Hyun Woong, Lee, Youn Jae, Park, Sung Jae, Yoo, Ki Young, Kim, Hyung Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493355/
https://www.ncbi.nlm.nih.gov/pubmed/26157749
http://dx.doi.org/10.3350/cmh.2015.21.2.125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493355/
https://www.ncbi.nlm.nih.gov/pubmed/26157749
http://dx.doi.org/10.3350/cmh.2015.21.2.125

Ejemplares similares